loading
Galectin Therapeutics Inc stock is traded at $4.645, with a volume of 207.89K. It is up +1.20% in the last 24 hours and up +19.10% over the past month. Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.
See More
Previous Close:
$4.59
Open:
$4.57
24h Volume:
207.89K
Relative Volume:
0.31
Market Cap:
$296.43M
Revenue:
-
Net Income/Loss:
$-45.08M
P/E Ratio:
-6.363
EPS:
-0.73
Net Cash Flow:
$-33.68M
1W Performance:
-21.80%
1M Performance:
+19.10%
6M Performance:
+193.99%
1Y Performance:
+71.40%
1-Day Range:
Value
$4.45
$4.7089
1-Week Range:
Value
$4.21
$6.55
52-Week Range:
Value
$0.726
$6.55

Galectin Therapeutics Inc Stock (GALT) Company Profile

Name
Name
Galectin Therapeutics Inc
Name
Phone
678-620-3186
Name
Address
4960 PEACHTREE INDUSTRIAL BOULEVARD, NORCROSS, GA
Name
Employee
15
Name
Twitter
@galectingalt
Name
Next Earnings Date
2025-03-31
Name
Latest SEC Filings
Name
GALT's Discussions on Twitter

Compare GALT with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
GALT
Galectin Therapeutics Inc
4.6273 294.04M 0 -45.08M -33.68M -0.73
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
387.15 99.26B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
597.07 62.06B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
447.07 59.21B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
729.15 44.94B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
341.62 36.57B 3.81B -644.79M -669.77M -6.24

Galectin Therapeutics Inc Stock (GALT) Upgrades & Downgrades

Date Action Analyst Rating Change
Jun-17-25 Resumed H.C. Wainwright Buy
Aug-13-20 Reiterated H.C. Wainwright Buy
Feb-13-19 Initiated B. Riley FBR Buy
Dec-07-17 Reiterated H.C. Wainwright Buy
Nov-28-17 Reiterated H.C. Wainwright Buy
Oct-19-17 Initiated ROTH Capital Buy
Mar-30-17 Upgrade H.C. Wainwright Neutral → Buy
Oct-03-16 Downgrade FBR & Co. Outperform → Mkt Perform
Sep-29-16 Downgrade H.C. Wainwright Buy → Neutral
Sep-28-16 Downgrade ROTH Capital Buy → Sell
Mar-28-16 Resumed H.C. Wainwright Buy
Sep-21-15 Initiated H.C. Wainwright Buy
Aug-01-14 Downgrade Aegis Capital Buy → Hold
Jul-30-14 Reiterated MLV & Co Buy
Jul-29-14 Reiterated MLV & Co Buy
Apr-02-14 Reiterated MLV & Co Buy
Feb-10-14 Reiterated Aegis Capital Buy
Jan-09-14 Reiterated Aegis Capital Buy
Dec-03-13 Initiated MLV & Co Buy
Aug-19-13 Reiterated Aegis Capital Buy
View All

Galectin Therapeutics Inc Stock (GALT) Latest News

pulisher
07:30 AM

Key metrics from Galectin Therapeutics Inc.’s quarterly dataPortfolio Value Summary & Weekly Setup with High ROI Potential - newser.com

07:30 AM
pulisher
04:30 AM

IPO Launch: Can Galectin Therapeutics Inc reach all time highs this yearMarket Performance Summary & Expert Verified Movement Alerts - خودرو بانک

04:30 AM
pulisher
04:20 AM

Analyst Calls: Whats next for Galectin Therapeutics Inc stockMarket Risk Analysis & Risk Managed Investment Strategies - خودرو بانک

04:20 AM
pulisher
01:48 AM

Tools to assess Galectin Therapeutics Inc.’s risk profileVolume Spike & Daily Growth Stock Tips - newser.com

01:48 AM
pulisher
Sep 17, 2025

Published on: 2025-09-17 20:08:02 - newser.com

Sep 17, 2025
pulisher
Sep 17, 2025

Published on: 2025-09-17 12:49:30 - newser.com

Sep 17, 2025
pulisher
Sep 17, 2025

Fund Flows: Will Galectin Therapeutics Inc outperform its industry peers2025 Top Gainers & Expert-Curated Trade Recommendations - خودرو بانک

Sep 17, 2025
pulisher
Sep 17, 2025

Market Leaders: Will Citius Oncology Inc benefit from sector rotationJuly 2025 Big Picture & Free AI Powered Buy and Sell Recommendations - خودرو بانک

Sep 17, 2025
pulisher
Sep 16, 2025

Aug Rallies: Does Galectin Therapeutics Inc have a sustainable dividend2025 Valuation Update & Long Hold Capital Preservation Plans - خودرو بانک

Sep 16, 2025
pulisher
Sep 16, 2025

Galectin Therapeutics Inc. stock prediction for this weekPortfolio Value Summary & Verified Swing Trading Watchlist - newser.com

Sep 16, 2025
pulisher
Sep 16, 2025

Will Galectin Therapeutics Inc. continue its uptrendRisk Management & Reliable Volume Spike Trade Alerts - newser.com

Sep 16, 2025
pulisher
Sep 16, 2025

Market reaction to Galectin Therapeutics Inc.’s recent newsEntry Point & Stepwise Trade Signal Implementation - newser.com

Sep 16, 2025
pulisher
Sep 16, 2025

How sentiment analysis helps forecast Galectin Therapeutics Inc.Buy Signal & Safe Capital Investment Plans - newser.com

Sep 16, 2025
pulisher
Sep 16, 2025

Aug Highlights: Does Galectin Therapeutics Inc have consistent dividend growthWall Street Watch & Technical Buy Zone Confirmation - خودرو بانک

Sep 16, 2025
pulisher
Sep 16, 2025

Galectin Therapeutics (NASDAQ:GALT) CFO Jack W. Callicutt Sells 8,706 Shares - MarketBeat

Sep 16, 2025
pulisher
Sep 16, 2025

Joel Lewis Sells 14,000 Shares of Galectin Therapeutics (NASDAQ:GALT) Stock - MarketBeat

Sep 16, 2025
pulisher
Sep 16, 2025

Income Plays: Will Galectin Therapeutics Inc outperform its industry peersMarket Risk Report & Free Safe Capital Growth Stock Tips - خودرو بانک

Sep 16, 2025
pulisher
Sep 16, 2025

Does Galectin Therapeutics Inc have consistent dividend growthEarnings Beat & Consistent Income Trade Ideas - خودرو بانک

Sep 16, 2025
pulisher
Sep 16, 2025

Technical signs of recovery in Galectin Therapeutics Inc.July 2025 Update & Expert Curated Trade Ideas - newser.com

Sep 16, 2025
pulisher
Sep 15, 2025

Volatility Watch: What is the long term forecast for Galectin Therapeutics Inc stock2025 EndofYear Setup & Free Low Drawdown Momentum Trade Ideas - خودرو بانک

Sep 15, 2025
pulisher
Sep 15, 2025

Galectin therapeutics CFO sells shares for $56,053 - Investing.com India

Sep 15, 2025
pulisher
Sep 15, 2025

Galectin therapeutics CFO sells shares for $56,053 By Investing.com - Investing.com Nigeria

Sep 15, 2025
pulisher
Sep 15, 2025

Bond Watch: Can Galectin Therapeutics Inc weather a recessionInsider Selling & Long-Term Safe Investment Ideas - خودرو بانک

Sep 15, 2025
pulisher
Sep 15, 2025

Breakout Move: Will Galectin Therapeutics Inc. face regulatory challengesTake Profit & Weekly Watchlist for Hot Stocks - خودرو بانک

Sep 15, 2025
pulisher
Sep 15, 2025

Quarterly Risk: Will The E.W. Scripps Company outperform the market in YEARMarket Sentiment Report & Consistent Profit Trading Strategies - خودرو بانک

Sep 15, 2025
pulisher
Sep 15, 2025

Galectin Therapeutics Inc. $GALT Shares Bought by Geneos Wealth Management Inc. - Defense World

Sep 15, 2025
pulisher
Sep 14, 2025

Published on: 2025-09-14 19:23:29 - newser.com

Sep 14, 2025
pulisher
Sep 14, 2025

Analyzing Galectin Therapeutics Inc. with risk reward ratio chartsTake Profit & Growth Focused Stock Pick Reports - newser.com

Sep 14, 2025
pulisher
Sep 14, 2025

Insider Trading At Galectin Therapeutics Inc (NASDAQ: GALT): What Did We Note? - stocksregister.com

Sep 14, 2025
pulisher
Sep 14, 2025

How to integrate Galectin Therapeutics Inc. into portfolio analysis toolsMarket Risk Summary & Entry Point Strategy Guides - newser.com

Sep 14, 2025
pulisher
Sep 14, 2025

Has Galectin Therapeutics Inc. found a price floorJuly 2025 Trends & Low Risk Profit Maximizing Plans - newser.com

Sep 14, 2025
pulisher
Sep 14, 2025

Tick level data insight on Galectin Therapeutics Inc. volatilityJobs Report & Free Fast Entry Momentum Trade Alerts - newser.com

Sep 14, 2025
pulisher
Sep 12, 2025

Is Galectin Therapeutics Inc. stock entering bullish territory2025 Stock Rankings & Weekly Watchlist of Top Performers - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

What Fibonacci levels say about Galectin Therapeutics Inc. reboundMarket Weekly Review & Step-by-Step Trade Execution Guides - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

Galectin Therapeutics Inc. (NASDAQ:GALT) Surges 27%; Individual Investors Who Own 53% Shares Profited Along With Insiders - 富途牛牛

Sep 12, 2025
pulisher
Sep 12, 2025

Galectin Therapeutics Inc. (GALT) Is Up 7.48% in One Week: What You Should Know - sharewise.com

Sep 12, 2025
pulisher
Sep 12, 2025

Will Galectin Therapeutics Inc. stock recover after recent dropRate Hike & Safe Entry Point Alerts - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

What technical models suggest about Galectin Therapeutics Inc.’s comebackTrade Signal Summary & Expert Approved Momentum Ideas - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

Is Galectin Therapeutics Inc. building a consolidation baseMarket Performance Summary & Low Risk High Win Rate Stock Picks - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

Chart based analysis of Galectin Therapeutics Inc. trendsQuarterly Trade Review & Long-Term Growth Portfolio Plans - Newser

Sep 12, 2025

Galectin Therapeutics Inc Stock (GALT) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Galectin Therapeutics Inc Stock (GALT) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
CALLICUTT JACK W
Chief Financial Officer
Sep 12 '25
Sale
6.44
8,706
56,054
7,614
LEWIS JOEL
President and CEO
Sep 12 '25
Option Exercise
2.39
14,000
33,460
846,592
LEWIS JOEL
President and CEO
Sep 12 '25
Sale
6.36
14,000
89,048
832,592
$35.70
price up icon 0.15%
$85.75
price up icon 1.09%
$28.03
price down icon 0.18%
$96.19
price down icon 2.02%
$144.81
price up icon 0.18%
biotechnology ONC
$341.80
price up icon 2.82%
Cap:     |  Volume (24h):